Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : bgix (biologix international ) -- Ignore unavailable to you. Want to Upgrade?

To: STOCK DOC who wrote (343)	4/11/1999 11:06:00 AM
From: ezXit	Respond to of 498

your BGIX shares are worth at least $1.50 copied from raging bull post 229 BGIX thread.... our shares are worth min 1.50 !!!!!!!!! do not sell your shares for less then 1.50 !!!!!! read last nov news ...it clearly states that THE health channel is doing a leveage buy out of BGIX at 1.50 per share ( BGIX was .10 then) ... so why sell for less then 1.50..... do NOT put in stop loss at this time !!!!! ????? now that the site is opened can we get a better buy out ?? will they give us some $$ plus shares in IPO ?? so when BGIX was .10 they made bid of $10mil to buy us out ......... we had mark-cap of 6.5mil shares X .10= $650K ..... so they offered us 1.54 per share X 6.5mil =$10mil ????? BGIX is worth 1.50 +++++++++++ SAN FRANCISCO--(BW HealthWire)--Nov. 19, 1998--BioLogix International, Ltd. (OTC BB:BGIX - news), reports The Health Channelÿ is revamping its slate of on-line commercial programs to better suit the needs of both large advertising customers and individual consumers. At the same time THC is said to be shaking up the roles of several of its key producers and contractors to improve the channel's network image and awareness. The Health Channelÿ (THC) currently carries a demonstration site at thehealthchannel.com, but behind the scenes has been undertaking an extensive development of on-line healthcare programming for both consumers and medical professionals. Under its prior purchase by BioLogix, THC holds the right to spin-off as an independent public company, and has recently made a tender offer to do a leveraged-buyout of BioLogix itself; at an estimated $1.50 per share. On advice of its underwriters the deal would allow THC to accelerate its own proposed public offering and become more aggressive with its current development schedule; while at the same time dramatically improving value to the BioLogix shareholders. Through its own and affiliate web-sites, THC is reported to be scoring approximately 3 million ''hits'' per month on a pilot-program basis. The channel currently offers customized personal and professional solutions, as well as whole new ''virtual windows to the world of healthcare.'' In anticipation of finalizing its deal with BioLogix, THC looks to steadily build its revenues from on-line advertising, pay-per-view and e-commerce throughout the coming year. Although the company is said to be maintaining the secrecy of much of its development activity, in what is becoming a highly competitive venture capital market, more information can be obtained at the web-site www.biologix.net and on a limited basis at 1-800/828-BGIX. from nov 12 news Although subject to shareholder approval, the deal appears to be a potential windfall for both companies. Under the terms of a proposed leveraged buy-out The Health Channelÿ would acquire approximately $7.6 Million in assets and nearly $1 Million in revenues; both of which are considered necessary for THC to accelerate its own proposed registration and initial public offering (IPO). At the same time, the BioLogix shareholders could receive a dramatically higher value for their current investment in the form of cash and stock worth over $1.50 per share. BioLogix is reported to have approximately 6.5 million issued and outstanding shares following completion of its recent reorganization, and is presently traded on the over-the-counter bulletin board market between $.10 and $.12 per share on a ''pre-filing'' basis.